Guggenheim Capital LLC Iovance Biotherapeutics, Inc. Transaction History

Guggenheim Capital LLC

  • $12 Billion
  • Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 98,940 shares of IOVA stock, worth $370,035. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98,940
Previous 109,820 9.91%
Holding current value
$370,035
Previous $1.03 Million 29.0%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$7.17 - $12.28 $78,009 - $133,606
-10,880 Reduced 9.91%
98,940 $732,000
Q3 2024

Nov 13, 2024
SELL
$7.28 - $11.9 $19,299 - $31,546
-2,651 Reduced 2.36%
109,820 $1.03 Million
Q2 2024

Aug 14, 2024
BUY
$7.78 - $14.19 $272,362 - $496,763
35,008 Added 45.19%
112,471 $902,000
Q1 2024

May 14, 2024
SELL
$7.59 - $17.47 $240,132 - $552,715
-31,638 Reduced 29.0%
77,463 $1.15 Million
Q4 2023

Feb 14, 2024
BUY
$3.3 - $8.89 $360,033 - $969,907
109,101 New
109,101 $886,000
Q4 2022

Feb 14, 2023
SELL
$5.62 - $10.0 $3,169 - $5,640
-564 Reduced 0.5%
111,286 $711,000
Q3 2022

Nov 14, 2022
SELL
$9.53 - $13.11 $159,160 - $218,950
-16,701 Reduced 12.99%
111,850 $1.07 Million
Q2 2022

Aug 15, 2022
BUY
$6.38 - $18.33 $98,494 - $282,978
15,438 Added 13.65%
128,551 $1.42 Million
Q1 2022

May 16, 2022
BUY
$12.38 - $19.1 $105,440 - $162,674
8,517 Added 8.14%
113,113 $1.88 Million
Q4 2021

Feb 14, 2022
BUY
$16.55 - $27.63 $153,865 - $256,876
9,297 Added 9.76%
104,596 $2 Million
Q3 2021

Nov 15, 2021
SELL
$20.35 - $26.63 $56,186 - $73,525
-2,761 Reduced 2.82%
95,299 $2.35 Million
Q2 2021

Aug 13, 2021
BUY
$16.33 - $33.07 $141,058 - $285,658
8,638 Added 9.66%
98,060 $2.55 Million
Q1 2021

May 13, 2021
BUY
$28.67 - $52.59 $574,088 - $1.05 Million
20,024 Added 28.85%
89,422 $2.83 Million
Q4 2020

Feb 16, 2021
SELL
$28.04 - $50.26 $371,333 - $665,593
-13,243 Reduced 16.02%
69,398 $3.22 Million
Q3 2020

Nov 13, 2020
SELL
$27.75 - $36.3 $831,417 - $1.09 Million
-29,961 Reduced 26.61%
82,641 $2.72 Million
Q2 2020

Aug 14, 2020
BUY
$27.21 - $41.0 $3.06 Million - $4.62 Million
112,602 New
112,602 $3.09 Million

Others Institutions Holding IOVA

# of Institutions
343
Shares Held
247M
Call Options Held
2.51M
Put Options Held
3.5M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $590M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email